AQR Capital Management - ADAMAS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,076,000
+71.9%
420,304
+93.9%
0.00%
+100.0%
Q1 2020$626,000
+245.9%
216,722
+354.3%
0.00%
Q4 2019$181,000
-39.3%
47,708
+220.3%
0.00%
Q3 2018$298,000
-27.0%
14,897
-5.8%
0.00%
Q2 2018$408,000
+36.5%
15,814
+26.5%
0.00%
Q1 2018$299,000
-3.9%
12,504
+36.3%
0.00%
Q4 2017$311,000
+10.3%
9,175
-7.9%
0.00%
Q4 2015$282,0009,9640.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders